Literature DB >> 33765906

Post-reversible cerebral vasoconstriction syndrome headache.

Yu-Hsiang Ling1,2, Yen-Feng Wang1,2, Jiing-Feng Lirng2,3, Jong-Ling Fuh1,2,4, Shuu-Jiun Wang1,2,4, Shih-Pin Chen5,6,7,8,9.   

Abstract

BACKGROUND: Chronic headache may persist after the remission of reversible cerebral vasoconstriction syndrome (RCVS) in some patients. We aimed to investigate the prevalence, characteristics, risk factors, and the impact of post-RCVS headache.
METHODS: We prospectively recruited patients with RCVS and collected their baseline demographics, including psychological distress measured by Hospital Anxiety and Depression scale. We evaluated whether the patients developed post-RCVS headache 3 months after RCVS onset. The manifestations of post-RCVS headache and headache-related disability measured by Migraine Disability Assessment (MIDAS) scores were recorded.
RESULTS: From 2017 to 2019, 134 patients with RCVS were recruited, of whom, 123 finished follow-up interviews (response rate 91.8%). Sixty (48.8%) patients had post-RCVS headache. Migrainous features were common in post-RCVS headache. Post-RCVS headache caused moderate-to-severe headache-related disability (MIDAS score > 10) in seven (11.7%) patients. Higher anxiety level (odds ratio 1.21, p = 0.009) and a history of migraine (odds ratio 2.59, p = 0.049) are associated with post-RCVS headache. Survival analysis estimated that 50% post-RCVS headache would recover in 389 days (95% confidence interval: 198.5-579) after disease onset.
CONCLUSIONS: Post-RCVS headache is common, affecting half of patients and being disabling in one-tenth. Higher anxiety level and migraine history are risk factors. Half of the patients with post-RCVS headache would recover in about a year.

Entities:  

Keywords:  Chronic headache; Prognosis; Prospective; Thunderclap headache; Vasospasm

Year:  2021        PMID: 33765906     DOI: 10.1186/s10194-021-01223-9

Source DB:  PubMed          Journal:  J Headache Pain        ISSN: 1129-2369            Impact factor:   7.277


  19 in total

Review 1.  Narrative review: reversible cerebral vasoconstriction syndromes.

Authors:  Leonard H Calabrese; David W Dodick; Todd J Schwedt; Aneesh B Singhal
Journal:  Ann Intern Med       Date:  2007-01-02       Impact factor: 25.391

2.  An RCVS Spectrum Disorder? New Daily Persistent Headache Starting as a Single Thunderclap Headache (3 New Cases).

Authors:  Sheheryar A Jamali; Todd D Rozen
Journal:  Headache       Date:  2019-03-04       Impact factor: 5.887

3.  Endothelial progenitor cells: a new key for endothelial dysfunction in migraine.

Authors:  Xiana Rodríguez-Osorio; Tomás Sobrino; David Brea; Francisco Martínez; José Castillo; Rogelio Leira
Journal:  Neurology       Date:  2012-07-18       Impact factor: 9.910

4.  Magnetic resonance angiography in reversible cerebral vasoconstriction syndromes.

Authors:  Shih-Pin Chen; Jong-Ling Fuh; Shuu-Jiun Wang; Feng-Chi Chang; Jiing-Feng Lirng; Ying-Chen Fang; Ben-Chang Shia; Jaw-Ching Wu
Journal:  Ann Neurol       Date:  2010-05       Impact factor: 10.422

5.  Recurrence of reversible cerebral vasoconstriction syndrome: a long-term follow-up study.

Authors:  Shih-Pin Chen; Jong-Ling Fuh; Jiing-Feng Lirng; Yen-Feng Wang; Shuu-Jiun Wang
Journal:  Neurology       Date:  2015-03-18       Impact factor: 9.910

6.  Long-Term Outcomes After Reversible Cerebral Vasoconstriction Syndrome.

Authors:  Rosalie Boitet; Solène de Gaalon; Claire Duflos; Grégory Marin; Jérôme Mawet; Cécilia Burcin; Caroline Roos; Ursula Fiedler; Marie-Germaine Bousser; Anne Ducros
Journal:  Stroke       Date:  2019-12-17       Impact factor: 7.914

7.  Long-term outcomes after reversible cerebral vasoconstriction syndrome.

Authors:  Seby John; Aneesh B Singhal; Leonard Calabrese; Ken Uchino; Tariq Hammad; Stewart Tepper; Mark Stillman; Brittany Mills; Tijy Thankachan; Rula A Hajj-Ali
Journal:  Cephalalgia       Date:  2015-06-18       Impact factor: 6.292

8.  Decreased number and function of endothelial progenitor cells in patients with migraine.

Authors:  S-T Lee; K Chu; K-H Jung; D-H Kim; E-H Kim; V N Choe; J-H Kim; W-S Im; L Kang; J-E Park; H-J Park; H-K Park; E-C Song; S K Lee; M Kim; J-K Roh
Journal:  Neurology       Date:  2008-03-19       Impact factor: 9.910

9.  Dynamic Changes in White Matter Hyperintensities in Reversible Cerebral Vasoconstriction Syndrome.

Authors:  Shih-Pin Chen; Kun-Hsien Chou; Jong-Ling Fuh; Yi-Hua Huang; Chu-Chung Huang; Jiing-Feng Lirng; Yen-Feng Wang; Ching-Po Lin; Shuu-Jiun Wang
Journal:  JAMA Neurol       Date:  2018-09-01       Impact factor: 18.302

10.  New daily persistent headache with a thunderclap headache onset and complete response to nimodipine (a new distinct subtype of NDPH).

Authors:  Todd D Rozen; Jennifer L Beams
Journal:  J Headache Pain       Date:  2013-12-23       Impact factor: 7.277

View more
  1 in total

Review 1.  Update of New Daily Persistent Headache.

Authors:  Kuan-Po Peng; Shuu-Jiun Wang
Journal:  Curr Pain Headache Rep       Date:  2022-01-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.